Osteobiologics and Value-Based Care: Challenges and Opportunities

Area of Science:

• Orthopedic Surgery
• Biomaterials Science
• Regenerative Medicine

Background:

• Autologous bone grafts are standard for spine surgery but carry risks.
• Bone allografts face availability issues.
• Osteobiologics are developed to mimic autografts, offering potential bone healing solutions.

Purpose of the Study:

• To explore challenges and opportunities of osteobiologics in spinal fusion.
• To evaluate various osteobiologics within a value-based care framework.

Main Methods:

• Comparative analysis of spinal fusion treatments.
• Evaluation of osteobiologics including bone morphogenetic proteins, platelet-rich plasma, autologous conditioned serum, demineralized bone matrix, biomaterial scaffolds, stem cells, and cellular bone matrices.

Main Results:

• Bone morphogenetic proteins are effective but risky; platelet-rich plasma lacks standardization.
• Autologous conditioned serum is inconclusive; demineralized bone matrix has variable efficacy.
• Biomaterial scaffolds show efficacy in spinal fusion; stem cells offer improved outcomes but have risks.
• Cellular bone matrices show promise but lack regulatory data.

Conclusions:

• Osteobiologics present potential for bone healing in spinal fusion.
• High cost and variable effectiveness of osteobiologics necessitate further research.
• Optimizing osteobiologic utilization within value-based care is crucial for patient outcomes.